Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on Fgf23 Trial (Soft)
NEPHRON（2016）
关键词
Fibroblast growth factor-23,Sevelamer,Chronic kidney disease,Phosphate binding therapy,Sevelamer on FGF23 trial,SoFT
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要